Maravai LifeSciences Holdings, Inc. MRVI TriLink — Restructuring
Similar metrics at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:RestructuringCharges.
The official record: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →
Ask your AI about Maravai LifeSciences Holdings, Inc.'s trilink — restructuring.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI

Claude
Questions, answered.
- What is Maravai LifeSciences Holdings, Inc.'s trilink — restructuring?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported trilink — restructuring of $2.14M in Q1 2026.
- How has Maravai LifeSciences Holdings, Inc.'s trilink — restructuring changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s trilink — restructuring decreased by 38.1% year-over-year, from $3.45M to $2.14M.
- What does trilink — restructuring mean?
- This captures the aggregate financial impact of strategic initiatives designed to reorganize the segment's business activities or cost structure. It is a key metric for evaluating management's ability to execute operational turnarounds and improve long-term profitability.